Alterations of Lipid Metabolism in the Heart in Spontaneously Hypertensive Rats Precedes Left Ventricular Hypertrophy and Cardiac Dysfunction

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Oct 14

PMID 36230994

Authors

Tomasz K Bednarski

Monika K Duda

Pawel Dobrzyn

Affiliations

Soon will be listed here.

Abstract

Disturbances in cardiac lipid metabolism are associated with the development of cardiac hypertrophy and heart failure. Spontaneously hypertensive rats (SHRs), a genetic model of primary hypertension and pathological left ventricular (LV) hypertrophy, have high levels of diacylglycerols in cardiomyocytes early in development. However, the exact effect of lipids and pathways that are involved in their metabolism on the development of cardiac dysfunction in SHRs is unknown. Therefore, we used SHRs and Wistar Kyoto (WKY) rats at 6 and 18 weeks of age to analyze the impact of perturbations of processes that are involved in lipid synthesis and degradation in the development of LV hypertrophy in SHRs with age. Triglyceride levels were higher, whereas free fatty acid (FA) content was lower in the LV in SHRs compared with WKY rats. The expression of de novo FA synthesis proteins was lower in cardiomyocytes in SHRs compared with corresponding WKY controls. The higher expression of genes that are involved in TG synthesis in 6-week-old SHRs may explain the higher TG content in these rats. Adenosine monophosphate-activated protein kinase phosphorylation and peroxisome proliferator-activated receptor α protein content were lower in cardiomyocytes in 18-week-old SHRs, suggesting a lower rate of β-oxidation. The decreased protein content of α/β-hydrolase domain-containing 5, adipose triglyceride lipase (ATGL) activator, and increased content of G0/G1 switch protein 2, ATGL inhibitor, indicating a lower rate of lipolysis in the heart in SHRs. In conclusion, the present study showed that the development of LV hypertrophy and myocardial dysfunction in SHRs is associated with triglyceride accumulation, attributable to a lower rate of lipolysis and β-oxidation in cardiomyocytes.

Citing Articles

Pharmacological and toxicological effects of Jiangfangbaoxin and determination of its components in the blood of spontaneously hypertensive rats.

Shi Z, Wang Q, Jia F, Li Q, Lu S Sci Rep. 2025; 15(1):4934.

PMID: 39929910 PMC: 11811156. DOI: 10.1038/s41598-025-88009-0.

Molecular remodeling in comorbidities associated with heart failure: a current update.

Appunni S, Rubens M, Ramamoorthy V, Saxena A, McGranaghan P, Khosla A Mol Biol Rep. 2024; 51(1):1092.

PMID: 39460797 PMC: 11512903. DOI: 10.1007/s11033-024-10024-7.

Independent risk factors of left ventricular hypertrophy in non-diabetic individuals in Sierra Leone - a cross-sectional study.

Xu Y, Jiang Y, Xu L, Zhou W, Zhang Z, Qi Y Lipids Health Dis. 2024; 23(1):259.

PMID: 39169399 PMC: 11337744. DOI: 10.1186/s12944-024-02232-8.

Hypertriglyceridemia: Molecular and Genetic Landscapes.

Scicchitano P, Amati F, Ciccone M, DAscenzi F, Imbalzano E, Liga R Int J Mol Sci. 2024; 25(12).

PMID: 38928071 PMC: 11203941. DOI: 10.3390/ijms25126364.

Association between the atherogenic index of plasma and left ventricular hypertrophy in patients with obstructive sleep apnea: a retrospective cross-sectional study.

Sun M, Liang C, Lin H, Chen Z, Wang M, Fang S Lipids Health Dis. 2024; 23(1):185.

PMID: 38867215 PMC: 11167813. DOI: 10.1186/s12944-024-02170-5.

References

Morelli M, Chavez C, Santulli G . Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders. Expert Opin Ther Targets. 2019; 24(1):79-88. PMC: 7169433. DOI: 10.1080/14728222.2020.1707806. View

Cetin Sanlialp S, Sanlialp M, Nar G, Malcok A . Triglyceride glucose index reflects the unfavorable changes of left ventricular diastolic functions and structure in uncomplicated newly diagnosed hypertensive patients. Clin Exp Hypertens. 2021; 44(3):215-222. DOI: 10.1080/10641963.2021.2018599. View

Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J . Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006; 312(5774):734-7. DOI: 10.1126/science.1123965. View

Sai E, Shimada K, Yokoyama T, Hiki M, Sato S, Hamasaki N . Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy. Heart Vessels. 2016; 32(2):166-174. DOI: 10.1007/s00380-016-0844-8. View

Fazio S, Major A, Swift L, Gleaves L, Accad M, Linton M . Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest. 2001; 107(2):163-71. PMC: 198874. DOI: 10.1172/JCI10310. View

Hall M, Maready M, Hall J, Stec D . Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation. Am J Physiol Endocrinol Metab. 2014; 307(3):E316-25. PMC: 4121577. DOI: 10.1152/ajpendo.00005.2014. View

Yecies J, Zhang H, Menon S, Liu S, Yecies D, Lipovsky A . Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011; 14(1):21-32. PMC: 3652544. DOI: 10.1016/j.cmet.2011.06.002. View

Wang Y, Viscarra J, Kim S, Sul H . Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol. 2015; 16(11):678-89. PMC: 4884795. DOI: 10.1038/nrm4074. View

Purushothaman S, Nair R, Harikrishnan V, Fernandez A . Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat. Mol Cell Biochem. 2011; 351(1-2):59-64. DOI: 10.1007/s11010-011-0711-y. View

10.

Wang H, Bell M, Sreenivasan U, Sreenevasan U, Hu H, Liu J . Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem. 2011; 286(18):15707-15. PMC: 3091179. DOI: 10.1074/jbc.M110.207779. View

11.

Lopaschuk G, Karwi Q, Tian R, Wende A, Abel E . Cardiac Energy Metabolism in Heart Failure. Circ Res. 2021; 128(10):1487-1513. PMC: 8136750. DOI: 10.1161/CIRCRESAHA.121.318241. View

12.

Marfella R, Di Filippo C, Portoghese M, Barbieri M, Ferraraccio F, Siniscalchi M . Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res. 2009; 50(11):2314-23. PMC: 2759838. DOI: 10.1194/jlr.P900032-JLR200. View

13.

Roe N, Handzlik M, Li T, Tian R . The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function. Sci Rep. 2018; 8(1):4983. PMC: 5862879. DOI: 10.1038/s41598-018-23223-7. View

14.

LEHMAN J, Barger P, Kovacs A, Saffitz J, Medeiros D, Kelly D . Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000; 106(7):847-56. PMC: 517815. DOI: 10.1172/JCI10268. View

15.

Reynolds L, Dutta R, Seeds M, Lake K, Hallmark B, Mathias R . FADS genetic and metabolomic analyses identify the ∆5 desaturase (FADS1) step as a critical control point in the formation of biologically important lipids. Sci Rep. 2020; 10(1):15873. PMC: 7522985. DOI: 10.1038/s41598-020-71948-1. View

16.

BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

17.

Xie X, Tie Y, Lai S, Zhang Y, Li H, Liu Y . Cardiac-specific CGI-58 deficiency activates the ER stress pathway to promote heart failure in mice. Cell Death Dis. 2021; 12(11):1003. PMC: 8548506. DOI: 10.1038/s41419-021-04282-7. View

18.

Jump D, Tripathy S, Depner C . Fatty acid-regulated transcription factors in the liver. Annu Rev Nutr. 2013; 33:249-69. PMC: 3940310. DOI: 10.1146/annurev-nutr-071812-161139. View

19.

Li J, Minczuk K, Massey J, Howell N, Roy R, Paul S . Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats. J Am Heart Assoc. 2020; 9(7):e015154. PMC: 7428616. DOI: 10.1161/JAHA.119.015154. View

20.

Shao W, Espenshade P . Expanding roles for SREBP in metabolism. Cell Metab. 2012; 16(4):414-9. PMC: 3466394. DOI: 10.1016/j.cmet.2012.09.002. View